CD38 is the main hydrolase of intracellular NAD+, and our previous studies showed that CD38 deficiency significantly protected against many cardiovascular diseases, such as cardiac hypertrophy, ischemia/reperfusion injury, and cardiomyocyte senescence [20,21,22]. This evidence concerns the gene CD38 and cardiovascular disorder.